Are patents and research compatible?
Article Abstract:
The US should seriously consider making changes to its Patent Act, which does not specifically permit some element of experimental use on a patented invention without the patent being regarded as infringed. This is particularly important for fields where there has been a strong rise in the number of patent applications but where additional research is usually necessary before a particular patented invention can be of benefit to society. In biotechnology, experimental use exemption is vital if the long-term aim of the patent system is to be maintained.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Public-sector patents on human DNA
Article Abstract:
New data shows that US public sector human DNA sequence patenting activity is approaching that of the private sector globally. The GENESEQ database was used to analyse patents including claims for human DNA sequences. 40% of the 652 patents were found to originate from the public sector, with half the patents filed by the private sector. Small US biotechnology companies accounted for 24%, while US multinationals had a relatively small stake.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: South Korean researchers under fire for claims of human cloning. Private deal puts Japanese researcher in hot water
- Abstracts: Speciation in the open ocean. Sympatric speciation in palms on an oceanic island. Speciation in the round
- Abstracts: Genetics and elephant conservation. Remembering elephants at CITES
- Abstracts: Structural basis for self-association and receptor recognition of human TRAF2. Sources of variations in patterns of plant-insect association
- Abstracts: Protective selective pressure. Design of potent selective zinc-mediated serine protease inhibitors. Human TNF mutants with selective activity on the p55 receptor